secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sagimet Biosciences Inc. (SGMT)
CIK:        0001400118
Form:       8-K
Filed at:   2026-06-12T20:06:12+00:00
Accession:  0001104659-26-073431
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Sagimet director Tim Walbert resigns; annual meeting ratifies board and auditor
-------------------------------------------------------------------------------

- Tim Walbert resigned from Board effective June 12, 2026, citing other commitments, no disagreement.
- All four Class III directors elected: Jarrett, Phillips, Happel, Kemble with 6.5M-8.8M votes for each.
- KPMG LLP ratified as independent auditor for FY 2026: 19.1M for, 14k against.
- Outstanding shares of Series A common stock: 32,017,613 as of record date April 17, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1400118/000110465926073431/0001104659-26-073431-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1400118/000110465926073431/tm2617560d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-073431

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer